Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

IGC Pharma (IGC) Assets Average (2016 - 2025)

IGC Pharma has reported Assets Average over the past 15 years, most recently at $8.8 million for Q3 2025.

  • Quarterly Assets Average fell 15.63% to $8.8 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $8.8 million through Sep 2025, down 15.63% year-over-year, with the annual reading at $9.3 million for FY2025, 31.13% down from the prior year.
  • Assets Average was $8.8 million for Q3 2025 at IGC Pharma, up from $8.3 million in the prior quarter.
  • Over five years, Assets Average peaked at $35.2 million in Q2 2021 and troughed at $8.3 million in Q2 2025.
  • The 5-year median for Assets Average is $16.4 million (2023), against an average of $19.1 million.
  • Year-over-year, Assets Average rose 28.94% in 2021 and then tumbled 43.19% in 2024.
  • A 5-year view of Assets Average shows it stood at $32.6 million in 2021, then tumbled by 35.46% to $21.0 million in 2022, then plummeted by 33.94% to $13.9 million in 2023, then decreased by 29.96% to $9.7 million in 2024, then decreased by 9.06% to $8.8 million in 2025.
  • Per Business Quant, the three most recent readings for IGC's Assets Average are $8.8 million (Q3 2025), $8.3 million (Q2 2025), and $8.9 million (Q1 2025).